Found 7 matching trials
Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
PHASE2This is an international, multicentre, parallel-group, randomised, double-b...
The Plasma Metabolomics Profiling of Primary Aldosteronism
N/APrimary aldosteronism (PA), characterized by overt renin-independent aldost...
Location
China Chongqing The third hospital affiliated to the Third Millitary Medical University
Lokelma for RAAS Maximisation in CKD & Heart Failure.
PHASE3Background: CKD in patients with heart failure (HF) is common and associate...
Location
St Georges, University of London
Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions
NAHeart Failure (HF) poses a major health burden in various populations, with...
Location
Kasralainy hospital, faculty of medicine, Cairo university
Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
N/AIn Germany nearly half of the population present elevated values of blood p...
Location
Multiple Locations
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
PHASE2Little is known about how some drugs affect inflammation or clotting factor...
Location
Vanderbilt University Medical Center
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
PHASE2This is a prospective, open-label trial to assess the efficacy of melanocor...
Location
California Institute of Renal Research